Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalfurafine Hydrochloride for Pruritus in Peritoneal Dialysis Patients
NCT07098351Recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Aug 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nalfurafine in chronic kidney disease-associated pruritus (CKD-aP), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Visual Analog Scale for Itch at 4 weeks. Started Aug 2025; status: recruiting.
02
Drugs
nalfurafine
03
Conditions
chronic kidney disease-associated pruritus (CKD-aP)
Beyond the preview
Go deeper on NCT07098351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07098351.